Testing a biomarker for Lewy body dementia diagnosis
Part of Brain & nervous system, Mental health clinical trials.
This study looks at a protein called alpha-synuclein in spinal fluid to see if it can help diagnose dementia with Lewy bodies and other related conditions. It may help doctors tell the difference between different types of dementia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older.
- You have symptoms that might be Lewy body disease, Alzheimer's disease, frontotemporal dementia, or a related condition.
- You have a caregiver or family member who can provide information about you if needed.
- You understand the study and can give informed consent (or have a legal representative who can).
- You are willing to have a lumbar puncture (spinal tap) and possibly an MRI scan.
- You have mild cognitive issues or dementia (MMSE score between 5 and 30).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood tests to help diagnose and track brain diseases (like Alzheimer's) or mental health conditions. It compares patients to healthy volunteers to find better ways to detect and monitor these illnesses.
This study helps people understand a protein called alpha-synuclein that may be related to memory problems and movement disorders. Researchers will either test your spinal fluid or skin to look for this protein, then discuss the results with you and measure how you're doing over time.
This study uses a combination of tests to improve diagnosis of dementia with Lewy bodies compared to Alzheimer's disease and healthy aging. You may help doctors identify the right diagnosis more accurately.
This study looks at how brain changes affect attention and thinking in people with Lewy body dementia. It includes brain scans, an EEG, and a medication option to see if it helps with symptoms.
This trial follows people with probable Lewy body dementia over several years to see how the brain changes on MRI and on memory/thinking tests. It may help researchers understand disease progression and improve future care for Lewy body dementia.
This study looks at how to distinguish Alzheimer’s disease, Lewy body dementia, and Parkinson’s disease when someone has memory and thinking problems. It may help doctors choose the most accurate diagnosis and treatment path for the right condition.
Hear when a new Dementia With Lewy Bodies (DLB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.